Filtering
- SF Easyhaler and charcoal
- SF0166 Topical Ophthalmic Solution
- SF1126
- SFX-01
- SG001
- SGI-110
- SGI-110 (guadecitabine)
- SGI-1776
- SGLT-2 inhibitors
- SGLT2 inhibitor
- SGLT2 inhibitors
- SGLT2i
- SGM-101
- SGN-30
- SGN-35
- SGN-40
- SGN-40 (anti-huCD40 mAb)
- SGN-75
- SGN-CD19A
- SGN-CD33A
- SGN-LIV1A
- SGN1
- SGT
- SGX523 Capsules
- SGX942
- SH-1028
- SH229
- SHAPE measurement (Sonazoid ultrasoud contrast agent)
- SHC014748M
- SHEN26 capsule
- SHEN26 placebo
- SHP465
- SHP615
- SHP626
- SHP640
- SHP655
- SHR-1209
- SHR-1209 ;placebo
- SHR-1209 Placebo
- SHR-1210
- SHR-1210+Apatinib
- SHR-1222
- SHR-1314
- SHR-1316
- SHR-1501
- SHR-1701
- SHR-1701、 BP102 、XELOX
- SHR-1701;BP102
- SHR-1702
- SHR-1703
- SHR-1707
- SHR-1819
- SHR-1905
- SHR-1906
- SHR-2004 injection
- SHR-A1811
- SHR-A1811;SHR-1701;capecitabine;oxaliplatin
- SHR-A1904
- SHR-A2009
- SHR-A2102
- SHR0302
- SHR0302 Ointment
- SHR0302 placebo
- SHR0302 placebo comparator
- SHR0302 tablets、Placebo
- SHR0410
- SHR0410 Injection
- SHR0532
- SHR0534
- SHR1210
- SHR1459
- SHR1459 ;YY-20394
- SHR1701
- SHR20004
- SHR2150
- SHR2150;Placebo
- SHR2285
- SHR2285 tablet
- SHR2554
- SHR3162
- SHR3680
- SHR3824
- SHR4640
- SHR4640 dose1
- SHR4640 tablet
- SHR6390
- SHR6508
- SHR6508;Placebo
- SHR7280
- SHR7280 tablets
- SHR7390
- SHR8554
- SHR8554 Injection
- SHR8554 Injection and SHR0410 Injection
- SI-614
- SI-6603
- SI-B001
- SI-B003
- SID142
- SIM0348
- SIM0417
- SIM1811-03
- SIMVASTATIN
- SJG-136
- SK-0403
- SK-1403
- SK-MS10
- SK-PC-B70M
- SK3530
- SKB264
- SKI-606
- SKI-606 (Bosutinib)
- SKI-O-703
- SKI-O-703 capsule
- SKLB1028
- SKY0402
- SL-1002
- SL-172154
- SL-401
- SLC-0111
- SLC-391
- SLGT2
- SLI-F06
- SLN124
- SLN360
- SLS-002
- SLS-005
- SLV-313 SR
- SLV213
- SLV320
- SLV334
- SLV337
- SLV354 capsules
- SLx-2101
- SLx-4090
- SM-1
- SM-13496
- SM-13496 (lurasidone HCl)
- SM-88
- SM03
- SM04690
- SM04755
- SM08502
- SMC placebo
- SMC with SP+AQ
- SMC021 Placebo
- SMOFlipid
- SMP-100
- SMT C1100
- SN132D
- SNA-120
- SNAC
- SNC-102 sustained release tablet
- SNDX-275
- SNDX-5613
- SNDX-6352
- SNF472
- SNG001
- SNN0029
- SNN0031
- SNO
- SNS-032 Injection
- SNS-301
- SNS-595
- SNX-5422
- SNX-5422 plus ibrutinib
- SOBI003
- SOC
- SOC + Placebo
- SOF
- SOF+DCV+SMV
- SOF/VEL
- SOF/VEL/VOX
- SOM 230 / Pasireotide
- SOM230
- SOR007 (Uncoated Nanoparticulate Paclitaxel) Ointment
- SOT101
- SOTB07
- SOV2012-F1
- SOX
- SP
- SP-02L (darinaparsin for injection)
- SP-102
- SP-103
- SP-104
- SP-420
- SP-624
- SP-8203
- SP01A
- SP16
- SP2086
- SPARC Placebo
- SPARC001 type I
- SPARC001 type II
- SPC3649
- SPC4955
- SPC5001
- SPD465
- SPD476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine
- SPD489